Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -296.84 | N/A |
| PEG Ratio (TTM) | 0.15 | N/A |
| P/S Ratio (TTM) | 1.38 | N/A |
| P/B Ratio (TTM) | 1.35 | N/A |
| P/FCF Ratio (TTM) | 10.23 | N/A |
| Price to 5YR AVG Earnings Ratio | 48.21 | N/A |
| Price to 5YR AVG FCF Ratio | 12.98 | N/A |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.12% | N/A |
| ROE (TTM) | -0.51% | N/A |
| Net Profit Margin (TTM) | -0.40% | N/A |
| ROIC 5YR AVG | 3.56% | N/A |
Growth (68%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -1,061.59% | -20.62% | 66.28% |
| Revenue | 3.36% | 18.75% | 32.61% |
| Net Income | -115.81% | 17.45% | 40.97% |
| Cash Flow | 20.99% | 18.46% | 12.68% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.87 | N/A |
| Quick Ratio (TTM) | 1.87 | N/A |
| D/E Ratio (TTM) | 2.01 | N/A |
| Interest Coverage (TTM) | 1.06 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.71 | N/A |
| LTL to 5YR AVG FCF | 15.68 | N/A |
| Shares Outstanding Growth 5YR AVG | 9.37% | N/A |